Cargando…
晚期非小细胞肺癌ALK融合基因及其他少见驱动基因阳性靶向治疗进展
Targeted therapy was one of the major treatments in advanced non-small cell lung cancer (NSCLC) with positive driver genes. This area of research progresses day by day, with novel target discoveries, novel drug development, and use of novel combination treatments. Researchers have also undergone dee...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973289/ https://www.ncbi.nlm.nih.gov/pubmed/28103976 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.01.10 |